A review of the literature concerning HIV and cigarette smoking: Morbidity and mortality, associations with individual- and social-level characteristics, and smoking cessation efforts

References

• Alexander C, Piazza M, Mekos D, Valente T. Peers, school, and adolescent cigarette smoking. Journal of Adolescent Health 2001; 29: 22–30
   PubMed Web of Science ®Google Scholar
• Arcavi L, Benowitz NL. Cigarette smoking and infection. Archives of Internal Medicine 2004; 164: 2206–2216
   PubMed Web of Science ®Google Scholar
• Aubin H-J, Bobak A, Britton JR, Oncken C, Billing CB, Jr, Gong J, , Reeves KR, et al. Varenicline versus transdermal nicotine patch for smoking cessation: Results from a randomised open-label trial. Thorax 2008; 63: 717–724
   PubMed Web of Science ®Google Scholar
• Barbaro G, Di Lorenzo G, Cirelli A, Grisorio B, Lucchini A, Hazra C, Barbarini G. An open-label, prospective, observational study of the incidence of coronary artery disease in patients with HIV infection receiving highly active antiretroviral therapy. Clinical Therapeutics 2003; 25: 2405–2418
   PubMed Web of Science ®Google Scholar
• Benard A, Bonnet F, Tessier J, Fossoux H, Dupon M, Mercie P, , Chene G, et al. Tobacco addiction and HIV infection: Toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort. AIDS Patient Care and STDs 2007; 21: 458–468
   PubMed Web of Science ®Google Scholar
• Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, , Shapiro M, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry 2001; 58: 721–728
   PubMed Web of Science ®Google Scholar
• Boarts JM, Bogart LM, Tabak MA, Armelie AP, Delahanty DL. Relationship of race, sexual orientation, and HIV-related discrimination with adherence to HIV treatment: A pilot study. Journal of Behavioral Medicine 2008; 31: 445–451
   PubMed Web of Science ®Google Scholar
• Bogart LM, Cogwill BO, Kennedy D, Ryan G, Murphy DA, Elijah J, Schuster MA. HIV-related stigma among people with HIV and their families: A qualitative analysis. AIDS and Behavior 2008; 12: 244–254
   PubMed Web of Science ®Google Scholar
• Burkhalter JE, Springer CM, Chabra R, Ostroff JS, Rapkin BD. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine and Tobacco Research 2005; 7: 511–522
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). (2011a). Current Cigarette Smoking Prevalence Among Working Adults – United States, 2004–2010. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6038a2.htm
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2011b). Tobacco use: Targeting the nation's leading killer at a glance 2011. Retrieved from http://www.cdc.gov/chronicdisease/resources/publications/aag/osh.htm
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2011c). Quitting smoking among adults – United States, 2001–2010. Retrieved from http://www.cdc.gov/tobacco/data_statistics/mmwrs/byyear/2011/mm6044a2/intro.htm
   Google Scholar
• Centers for Disease Control and Prevention (CDC). (2013). Quitting smoking. Retrieved from http://www.cdc.gov/tobacco/data_statistics/fact_sheets/cessation/quitting/index.htm#methods
   Google Scholar
• Chander G, Stanton C, Hutton HE, Abrams DB, Pearson J, Knowlton A, , Niaura R, et al. Are smokers with HIV using information and communication technology? Implications for behavioral interventions. AIDS and Behavior 2012; 16: 383–388
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, Pfeiffer RM, Chang L, Goedert JJ, Biggar RJ, Engels EA. Elevated risk of lung cancer among people with AIDS. AIDS 2007; 21: 207–213
   PubMed Web of Science ®Google Scholar
• Cheong Y, Yong HH, Borland R. Does how you quit affect success? A comparison between abrupt and gradual methods using data from the International Tobacco Control Policy Evaluation Study. Nicotine and Tobacco Research 2007; 9: 801–810
   PubMedGoogle Scholar
• Christakis NA, Fowler JH. The collective dynamics of smoking in a large social network. The New England Journal of Medicine 2008; 358: 2249–2258
   PubMed Web of Science ®Google Scholar
• Clifford GM, Lise M, Franceschi S, Egger M, Bouchardy C, Korol D, , Schöni-Affolter F, et al. Lung cancer in the Swiss HIV Cohort Study: Role of smoking, immunodeficiency and pulmonary infection. British Journal of Cancer 2012; 106: 447–452
   Google Scholar
• Coates RA, Farewell VT, Raboud J, Read SE, MacFadden DK, Calzavara LM, , Fanning MM, et al. Cofactors of progression to acquired immunodeficiency syndrome in a cohort of male sexual contacts of men with human immunodeficiency virus disease. American Journal of Epidemiology 1990; 132: 717–722
   PubMed Web of Science ®Google Scholar
• Collins RL, Kanouse DE, Gifford AL, Senterfitt JW, Schuster MA, McCaffrey DF, , Wenger NS, et al. Changes in health-promoting behavior following diagnosis with HIV: Prevalence and correlates in a national probability sample. Health Psychology 2001; 20: s351–s360
   PubMed Web of Science ®Google Scholar
• Crothers K, Goulet JL, Rodriguez-Barradas MC, Gibert CL, Butt AA, Braithwaite RS, , Justice AC, et al. Decreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans. Journal of General Internal Medicine 2007; 22: 749–754
   PubMed Web of Science ®Google Scholar
• Crothers K, Griffith TA, McGinnis KA, Rodriguez-Barradas MC, Leaf DA, Weissman S, , Justice AC, et al. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. Journal of General Internal Medicine 2005; 20: 1142–1145
   PubMed Web of Science ®Google Scholar
• Cui Q, Robinson L, Elston D, Smaill F, Cohen J, Quan C, , Smieja M, et al. Safety and tolerability of varenicline tartrate (champix(®)/chantix (®)) for smoking cessation in HIV-infected subjects: A pilot open-label study. AIDS Patient Care STDS 2011; 26: 12–19
   PubMedGoogle Scholar
• Diemert LM, Bondy SJ, Brown KS, Manske S. Young adult smoking cessation: Predictors of quit attempts and abstinence. American Journal of Public Health 2013; 103: 449–453
   PubMed Web of Science ®Google Scholar
• Elzi L. Spoerl, D., Voggensperger, J., Nicca, D., Simcock, M., Bucher, H.C., … Battegay, M., and the Swiss HIV Cohort Study. 2006, A smoking cessation programme in HIV-infected individuals: a pilot study. Antiviral Therapy, 11, 787–795
   Google Scholar
• Encrenaz G, Rondeau BV, Bonnet F, Lazaro E, Neau D, Dupon M, , Chene G, et al. Determinants of smoking cessation attempts among HIV-infected patients from a hospital-based prospective cohort. Current HIV Research 2010; 8: 212–217
   PubMed Web of Science ®Google Scholar
• Engels EA, Brock MV, Chen J, Hooker CM, Gillison M, Moore RD. Elevated incidence of lung cancer among HIV-infected individuals. Journal of Clinical Oncology 2006; 24: 1383–1388
   PubMed Web of Science ®Google Scholar
• Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, Watts H, , Anastos K, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: A report from the Women's Interagency HIV Study. American Journal of Public Health 2006; 96: 1060–1065
   PubMed Web of Science ®Google Scholar
• Ferrando SJ, Freyberg Z. Treatment of depression in HIV positive individuals: A critical review. International Review of Psychiatry 2008; 20: 61–71
   PubMed Web of Science ®Google Scholar
• Fiore M. Treating tobacco use and dependence: An introduction to the US Public Health Service Clinical Practice Guidelines. Respiratory Care 2000; 45: 1196–1199
   PubMedGoogle Scholar
• Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, Dorfman SF, Wewers ME, et al. Treating tobacco use and dependence: 2008 update. Clinical practice guidelines. U.S. Department of Health and Human Services, Rockville, MD 2008
   Google Scholar
• Food and Drug Administration. (2009). Public health advisory: FDA requires new boxed warnings for the smoking cessation drugs chantix and zyban. Retrieved from http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm169988.htm
   Google Scholar
• Friis-Møller N, Sabin CA, Weber R, d’Arminio Monforte A, El-Sadr WM, Reiss P, , Lundgren JD, et al. Combination antiretroviral therapy and the risk of myocardial infarction. New England Journal of Medicine 2003; 349: 1993–2003
   PubMed Web of Science ®Google Scholar
• Furber AS, Maheswaran R, Newell JN, Carroll C. Is smoking tobacco an independent risk factor for HIV infection and progression to AIDS? A systematic review. Sexually Transmitted Infections 2007; 83: 41–46
   PubMed Web of Science ®Google Scholar
• Fuster M, Estrada V, Fernandez-Pinilla MC, Fuentes-Ferrer ME, Teller MJ, Vergas J, , Fernandez-Cruz A, et al. Smoking cessation in HIV patients: Rate of success and associated factors. HIV Medicine 2009; 10: 614–619
   PubMedGoogle Scholar
• Galai N, Park LP, Wesch J, Visscher B, Riddler S, Margolic JB. Effect of smoking on the clinical progression of HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes and Human Retrivirology 1997; 14: 451–458
   PubMedGoogle Scholar
• Goldberg D, Weber KM, Orsi J, Hessol NA, D'souza G, Watts DH, , Cohen MH, et al. Smoking cessation among women with and at risk for HIV: Are they quitting?. Journal of General Internal Medicine 2010; 25: 39–44
   PubMed Web of Science ®Google Scholar
• Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, , Reeves KR, et al. Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation. JAMA 2006; 296: 47–55
   PubMed Web of Science ®Google Scholar
• Gritz ER, Vidrine DJ, Fingeret MC. Smoking cessation: A critical component of medical management in chronic disease populations. American Journal of Prevention Medicine 2007; 33: S414–S422
   PubMed Web of Science ®Google Scholar
• Gritz ER, Vidrine DJ, Lazev AB, Amick BC, III, Arduino RC. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine and Tobacco Research 2004; 6: 71–77
   PubMed Web of Science ®Google Scholar
• Helleberg M, Afzal S, Kronborg G, Larsen CS, Pedersen G, Pedersen C, , Obel N, et al. Mortality attributable to smoking among HIV-1-infected individuals: A nationwide, population-based cohort study. Clinical Infectious Diseases 2013; 56: 727–734
   PubMed Web of Science ®Google Scholar
• Horvath KJ, Eastman M, Prosser R, Goodroad B, Worthington L. Addressing smoking during medical visits: Patients with human immunodeficiency virus. American Journal of Prevention Medicine 2012; 43: S214–S221
   Google Scholar
• Humfleet GL, Delucchi K, Kelley K, Hall SM, Dilley J, Harrison G. Characteristics of HIV-positive cigarette smokers: A sample of smokers facing multiple challenges. AIDS Education and Prevention 2009; 21: 54–64
   PubMed Web of Science ®Google Scholar
• Huttunen R, Heikkinen T, Syrjanen J. Smoking and the outcome of infection. Journal of Internal Medicine 2011; 269: 258–269
   PubMed Web of Science ®Google Scholar
• Ingersoll KS. Cropsey, K.L., & Heckman, C.J. 2009, A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS and Behavior, 13, 545–554
   Google Scholar
• Jorenby DE, Taylor Hays J, Rigotit NA, Azoulay S, Watsky EJ, Williams KE, , Reeves KR, et al. Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation. JAMA 2006; 296: 56–63
   PubMed Web of Science ®Google Scholar
• Joseph AM, Hecht SS, Murphy SE, Lando H, Carmella SG, Gross M, , Hatsukami DK, et al. Smoking reduction fails to improve clinical and biological markers of cardiac disease: A randomized controlled trial. Nicotine and Tobacco Research 2008; 10: 471–481
   PubMed Web of Science ®Google Scholar
• Kirk GD, Merlo C, O’ Driscoll P, Mehta SH, Vlahov D, Samet J, Engels EA. HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clinical Infectious Diseases 2007; 45: 103–110
   PubMed Web of Science ®Google Scholar
• Kohli R, Lo Y, Homel P, Flanigan TP, Gardner LI, Howard AA, , Schoenbaum EE, et al. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. Clinical Infectious Diseases 2006; 43: 90–98
   PubMed Web of Science ®Google Scholar
• Kwong J, Bouchard-Miller K. Smoking cessation for persons living with HIV: A review of currently available interventions. Journal of the Association of Nurses in AIDS Care 2010; 21: 3–10
   PubMedGoogle Scholar
• Lazev AB. Vidrine, D.J., Arduino, R.C., & Gritz, E.R. 2004, Increasing access to smoking cessation treatment in a low-income, HIV-positive population: The feasibility of using cellular telephones. Nicotine & Tobacco Research, 6, 281–286
   Google Scholar
• Lazo M, Gange SJ, Wilson TE, Anastos K, Ostrow DG, Witt MD, Jacobson LP. Patterns and predictors of changes in adherence to highly active antiretroviral therapy: Longitudinal study of men and women. Clinical Infectious Diseases 2007; 45: 1377–1385
   PubMed Web of Science ®Google Scholar
• Levine AM, Seaberg EC, Hessol NA, Preston-Martin S, Silver S, Cohen MH, , Watts DH, et al. HIV as a risk factor for lung cancer in women: Data from the Women's Interagency HIV Study. Journal of Clinical Oncology 2010; 28(9): 1514–1519
   Google Scholar
• Lewden C, Salmon D, Morlat P, Bévilacqua S, Jougla E, Bonnet F, , Chêne G, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: Emerging role of hepatitis and cancers, persistent role of AIDS. International Journal of Epidemiology 2005; 34: 121–130
   PubMed Web of Science ®Google Scholar
• Lifson AR, Neuhaus J, Arribas JR, van den Berg-Wolf M, Labriola AM, Read TRH. Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy Clinical Trial. American Journal of Public Health 2010; 100: 1896–1903
   PubMed Web of Science ®Google Scholar
• Lloyd-Richardson EE, Stanton CA, Papandonatos GD, Betancourt REM, Stein M, Tashima K, , Niaura R, et al. HIV-positive smokers considering quitting: Differences by race/ethnicity. American Journal of Health Behavior 2008; 32: 3–15
   PubMedGoogle Scholar
• Lloyd-Richardson EE. Stanton, C.A., Papandonatos, G.D., Shadel, W.G., Stein, M., Tashima, K., … Niaura, R. 2009, Motivation and patch treatment for HIV+ smokers: A randomized controlled trial. Addiction, 104, 1891–1900
   Google Scholar
• Mamary EM, Bahrs D, Martinez S. Cigarette smoking and desire to quit among individuals living with HIV. AIDS Patient Care and STDs 2002; 16: 39–42
   PubMed Web of Science ®Google Scholar
• Marshall MM, Kirk GD, Caporaso NE, McCormack MC, Merlo CA, Hague JC, , Engels EA, et al. Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users. Addictive Behaviors 2011; 36: 61–67
   PubMed Web of Science ®Google Scholar
• Mermelstein R, Cohen S, Lichtenstein E, Baer JS, Kamarck T. Social support and smoking cessation and maintenance. Journal of Consulting and Clinical Psychology 1986; 54: 447–453
   PubMed Web of Science ®Google Scholar
• Miguez-Burbano MJ, Ashkin D, Rodriguez A, Duncan R, Pitchenik A, Quintero N, , Shor-Posner G, et al. Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease. International Journal of Infectious Disease 2005; 9: 208–217
   PubMed Web of Science ®Google Scholar
• Mihalak KB, Carroll FI, Luetje CW. Varenicline is a partial agonist at α4β2 and a full agonist at α7 neuronal nicotinic receptors. Molecular Pharmacology 2006; 70: 801–805
   PubMed Web of Science ®Google Scholar
• Moadel AB, Bernstein SL, Mermelstein RJ, Arnsten JH, Dolce EH, Shuter J. A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers. Journal of Acquired Immune Deficiency Syndrome 2012; 61: 208–215
   PubMed Web of Science ®Google Scholar
• Modrich L, Scherzer R, Zolopa A, Rimland D, Lewis CE, Bacchetti P, , Tien PC, et al. Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the HAART era. Journal of Acquired Immune Deficiency Syndrome 2010; 53: 102–106
   PubMedGoogle Scholar
• Nakagawa F, May M, Phillips A. Life expectancy living with HIV: Recent estimates and future implications. Current Opinion in Infectious Disease 2013; 26: 17–25
   PubMed Web of Science ®Google Scholar
• Niaura R, Abrams DB. Smoking cessation: Progress, priorities, and prospectus. Journal of Consulting and Clinical Psychology 2002; 70: 494–509
   PubMed Web of Science ®Google Scholar
• Nieman RB, Fleming J, Cocker RJ, Harris JR, Mitchell DM. The effect of cigarette smoking on the development of AIDS in HIV-1 seropositive individuals. AIDS 1993; 7: 705–710
   PubMed Web of Science ®Google Scholar
• Oncken C, Gonzales D, Nides M, Rennard S, Watsky E, Billing CB, , Reeves K, et al. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Archives of Internal Medicine 2006; 166: 1571–1577
   PubMed Web of Science ®Google Scholar
• Pacek LR. Latkin, C., Crum, R.M., Stuart, E.A., & Knowlton, A.R. 2013, Current cigarette smoking among HIV-positive current and former drug users: Associations with individual and social characteristics. AIDS and Behavior. [Epub ahead of print]. doi: 10.1007/s10461-013-0663-1
   Google Scholar
• Pacek LR. Latkin, C., Crum, R.M., Stuart, E.A., & Knowlton, A.R. 2014, Interest in quitting and lifetime quit attempts among smokers living with HIV infection. Drug and Alcohol Dependence, 138, 220–224
   Google Scholar
• Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, , Burk R, et al. Cervicovaginal human papilloma- virus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. Journal of the National Cancer Institute 1999; 91: 226–236
   PubMed Web of Science ®Google Scholar
• Palefsky JM, Shiboski S, Moss A. Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men. Journal of Acquired Immune Deficiency Syndrome 1994; 7: 599–606
   PubMedGoogle Scholar
• Palella FJ, Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holberg SD. Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV out-patient study. Journal of Acquired Immune Deficiency Syndrome 2006; 43: 27–34
   PubMed Web of Science ®Google Scholar
• Palella FJ, Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Atten GA, , Holberg SD, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New England Journal of Medicine 1998; 338: 853–860
   PubMed Web of Science ®Google Scholar
• Patel P. Hanson, D.L., Sullivan, P.S., Novak, R.M., Moorman, A.C., Tong, T.C., … Brooks, J.T. 2008, Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Annals of Internal Medicine, 148, 728–744
   Google Scholar
• Pedro-Clotet E, Deig-Comerma E, Ribell-Bachs M, Vidal-Castell I, García-Rodríguez P, Soler A. Bupropion use for smoking cessation in HIV-infected patients receiving antiretroviral therapy. Enfermedades Infecciosas y Microbiología Clínica 2006; 24: 509–511
   PubMedGoogle Scholar
• Petoumenos K, Worm S, Reiss P, de Wit S, d’Arminio Monforte A, Sabin C, , Law M, et al. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: Results from the D:A:D study. HIV Medicine 2011; 12: 412–421
   PubMed Web of Science ®Google Scholar
• Pines H, Koutsky L, Buskin S. Cigarette smoking and mortality among HIV-infected individuals in Seattle, Washington (1996–2008). AIDS and Behavior 2011; 15: 243–251
   PubMed Web of Science ®Google Scholar
• Rabkin JG, Goetz RR, Remien RH, Williams JB, Todak G, Gorman JM. Stability of mood despite HIV illness progression in a group of homosexual men. American Journal of Psychiatry 1997; 154: 231–238
   PubMed Web of Science ®Google Scholar
• Reynolds NR, Neidig JL, Wewers ME. Illness representation and smoking behavior: A focus group study of HIV-positive men. Journal of the Association of Nurses in AIDS Care 2004; 15: 38–46
   PubMedGoogle Scholar
• Rice VH. Hartmann-Boyce, J., & Stead, L.F. 2013, Nursing interventions for smoking cessation. Cochrane Database of Systematic Reviews, Issue 8. Article Number: CD001188
   Google Scholar
• Riley ED, Gandhi M, Hare C, Cohen J, Hwang S. Poverty, unstable housing, and HIV infection among women living in the United States. Current HIV/AIDS Reports 2007; 4: 181–186
   PubMedGoogle Scholar
• Savès M, Chêne G, Ducimetière P, Leport C, Le Moal G, Amouyel P, , Raffi F, et al. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clinical Infectious Diseases 2003; 37: 292–298
   PubMed Web of Science ®Google Scholar
• Schane RE, Ling PM, Glantz SA. Health effects of light and intermittent smoking: A review. Circulation 2010; 121: 1518–1522
   PubMed Web of Science ®Google Scholar
• Schnoll RA, Martinez E, Tatum KL, Glass M, Bernath A, Ferris D, Reynolds P. Increased self-efficacy to quit and perceived control over withdrawal symptoms predict smoking cessation following nicotine dependence treatment. Addictive Behaviors 2011; 36: 144–147
   PubMed Web of Science ®Google Scholar
• Shapiro AE, Tshabangu N, Golub JE, Martinson NA. Intention to quit smoking among human immunodeficiency virus infected adults in Johannesburg, South Africa. The International Journal of Tuberculosis and Lung Disease 2011; 15: 140–142
   PubMed Web of Science ®Google Scholar
• Shuter J, Bernstein SL. Cigarette smoking is an independent predictor nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine & Tobacco Research 2008; 10: 731–736
   PubMed Web of Science ®Google Scholar
• Shuter J, Bernstein SL, Moadel AB. Cigarette smoking behaviors and beliefs in persons living with HIV/AIDS. American Journal of Health Behavior 2012a; 36: 75–85
   PubMed Web of Science ®Google Scholar
• Shuter J, Salmo LN, Shuter AD, Nivasch EC, Moadel AB. Provider beliefs and practices relating to tobacco use in patients living with HIV/AIDS: A national survey. AIDS and Behavior 2012b; 16: 288–294
   PubMed Web of Science ®Google Scholar
• Sigel K, Wisnivesky J, Gordon K, Dubrow R, Justice A, Brown ST, , Crothers K, et al. HIV as an independent risk factor for incident lung cancer. AIDS 2012; 26: 1017–1025
   PubMed Web of Science ®Google Scholar
• Slemmer JE, Martin RM, Damaj MI. Bupropion is a nicotinic antagonist. Journal of Pharmacology and Experimental Therapeutics 2000; 295: 321–327
   PubMed Web of Science ®Google Scholar
• Stead LF, & Lancaster, T. (2007). Interventions to reduce harm from continued tobacco use. Cochrane Database of Systematic Reviews, Issue 3. Article Number: CD005231
   Google Scholar
• Stead LF. Perera, R., Bullen, C., Mant, D., & Lancaster, T. 2008, Nicotine replacement therapy for smoking cessation. Cocharane Database of Systematic Reviews, 1. Retrieved from http://mrw.interscience.wiley.com/ cochrane/clsysrev/articles/CD000146/frame.html
   Google Scholar
• Stewart DW, Jones GN, Minor KS. Smoking, depression, and gender in low-income African Americans with HIV/AIDS. Behavioral Medicine 2012; 37: 77–80
   Google Scholar
• Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE. Smoking among HIV positive New Yorkers: Prevalence, frequency, and opportunities for cessation. AIDS and Behavior 2010; 14: 824–835
   PubMed Web of Science ®Google Scholar
• Tønnesen P, Carrozzi L, Fagerström KO, Gratziou C, Jimenez-Ruiz C, Nardini S, , West R, et al. Smoking cessation in patients with respiratory diseases: A high priority, integral component of therapy. European Respiratory Journal 2007; 29: 390–417
   PubMed Web of Science ®Google Scholar
• Tornero C, Mafé C. Varenicline and antiretroviral therapy in patients with HIV. Journal of Acquired Immune Deficiency Syndrome 2006; 52: 656
   Google Scholar
• Turner J, Page-Shafer K, Chin DP, Osmond D, Mossar M, Markstein L, , Chesney M, et al. Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection. AIDS Patient Care and STDS 2001; 15: 615–624
   PubMed Web of Science ®Google Scholar
• Unger JB, Chen X. The role of social networks and media receptivity in predicting age of smoking initiation: A proportional hazard model of risk and protective factors. Addictive Behaviors 1999; 24: 371–381
   PubMed Web of Science ®Google Scholar
• Vidrine DJ, Arduino RC, Lazev AB, Gritz ER. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS 2006; 20: 253–260
   PubMed Web of Science ®Google Scholar
• Vidrine DJ. Marks, R.M., Arduino, R.C., & Gritz, E.R. 2011, Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine & Tobacco Research, 14, 106–110
   Google Scholar
• Webb MS, Vanable PA, Carey MP, Blair DC. Medication adherence in HIV-infected smokers: The mediating role of depressive symptoms. AIDS Education and Prevention 2009; 21: 94–105
   PubMed Web of Science ®Google Scholar
• Wewers ME, Neidig JL, Kihm KE. The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers. Journal of the Association of Nurses in AIDS Care 2000; 11: 37–44
   PubMedGoogle Scholar
• World Health Organization (WHO). (2011). WHO Report on the Global Tobacco Epidemic, 2011: Warning about the dangers of tobacco. Retrieved from http://whqlibdoc.who.int/publications/2011/9789240687813_eng.pdf.
   Google Scholar
• Yuan Y, L'Italien G, Mukherjee J, Iloeje UH. Determinants of discontinuation of initial highly active antiretroviral therapy regimens in a US HIV-infected patient cohort. HIV Medicine 2006; 7: 156–162
   PubMed Web of Science ®Google Scholar
• Ziedonis D, Hitsman B, Beckham JC, Zvolensky M, Adler LE, Audrain-McGovern J, , Riley WT, et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine and Tobacco Research 2008; 10: 1691–1715
   PubMed Web of Science ®Google Scholar
• Zhu SH, Melicer T, Sun J, Rosbrook B, Pierce JP. Smoking cessation with and without assistance: A population-based analysis. American Journal of Preventative Medicine 2000; 18: 305–311
   PubMed Web of Science ®Google Scholar